Universal Genotyping in Tuberculosis Control Program, New York City, 2001–2003
Carla M. Clark*
, Cynthia R. Driver*, Sonal S. Munsiff*†, Jeffrey R. Driscoll‡, Barry N. Kreiswirth§, Benyang Zhao¶, Adeleh Ebrahimzadeh¶, Max Salfinger‡, Amy S. Piatek*, Jalaa' Abdelwahab†, and the New York City Molecular Epidemiology Working Group
Author affiliations: *New York City Department of Health and Mental Hygiene, New York, New York, USA; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ‡New York State Department of Health's Wadsworth Center, Albany, New York, USA; §Public Health Research Institute, Newark, New Jersey, USA; ¶Public Health Laboratories, New York, New York, USA
Figure A1. Summary of tuberculosis (TB) genotyping activities, New York City, 2001–2003. NYC, New York City; LJ, Lowenstein-Jensen; RFLP, restriction fragment length polymorphism.
Page created: January 06, 2012
Page updated: January 06, 2012
Page reviewed: January 06, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.